Angina Studies

1. Double-blind evaluation of XXX in doses ranging from 15 mg/24 hrs to 105 mg/24 hrs. vs placebo in the treatment of angina pectoris.
2. XXX and XXX: A double-blind study of the safety and efficacy in the treatment of stable-effort-induced angina.
3. A double-blind parallel comparison of XXX with placebo in the treatment of symptomatic and non-symptomatic myocardial ischemia.
4. An eight-week double-blind placebo-controlled dose response study using XXX GITS as initial therapy for the treatment of chronic stable angina pectoris.
5. A multicenter placebo controlled study to assess the effects of oral XXX on treadmill exercise tolerance in patients with stable angina pectoris.
6. Dose ranging evaluation of XXX hydrochloride sustained release capsules vs placebo in patients with chronic stable angina pectoris.
7. Dose Response evaluation of XXX sustained release versus placebo in patients with chronic stable angina pectoris.
8. Double-blind parallel efficacy and safety study of various doses XX43285-193 XXX vs placebo in patients with chronic stable angina pectoris.
9. Double-blind, forced titration evaluation of four doses of XXX and placebo in the treatment of chronic stable angina.
10. XXX randomized placebo withdrawal angina and ischemia study (XXX).
11. A randomized, double-blind, placebo-controlled, parallel group study of the efficacy and safety of 4-week treatment with XXX in patients with chronic stable angina pectoris.
12. XXX multicenter exercise tolerance efficacy trial: A double-blind, placebo controlled, randomized parallel study of intermittent therapy in patients with chronic stable angina.
13. Efficacy and safety evaluation of three doses of GITS XXX in the treatment of stable angina pectoris.
14. A multicenter pilot study to assess safety and efficacy of XXX in patients with angina pectoris.
15. Acute effects of XXX in angina patients.
16. A comparison of the effects of XXX versus placebo in patients receiving concomitant beta-blocker therapy for chronic stable angina pectoris.
17. A Comparison of the Effects of XXX Versus Placebo for Three Weeks in Patients with Chronic Stable Angina Pectoris.
18. A Randomized, Multicenter Double-Blind, Placebo-Controlled Forced Dose Titration Study Comparing XXX 240 mg/480 mg to Norvasc 5 mg/10 mg with and Without XXX 50 mg in Patients with Chronic Stable Angina.
19. Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of Escalating Multiple Doses of XXX in Patients with Chronic Stable Coronary Artery Disease.
20. A Phase II, Randomized, Double-Blind, Multicenter, Acetyl-salicylic Acid-Controlled, Multidose Study of XXX in Patients with Coronary Artery Disease.
21. A Phase II, Randomized, Open-Label, Crossover, Multicenter, Multi-Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of XXX in Combination with Aspirin in Patients with Coronary Artery Disease.
22. A Randomized, Double-Blind, Placebo-controlled Dose Ranging Study of a 7-Day Course of XXX in Patients With Atherosclerotic Cardiovascular, Peripheral Vascular and/or Cerebrovascular Disease.